Pounded by both sides of the political aisle, pharmaceutical companies know what it feels like to be whipsawed by opposite ends of...
Mayo Clinic struck two joint ventures to develop and commercialize AI diagnostic tools. The idea was to develop algorithms to support clinicians’...
As healthcare leaders reflect on one year of the pandemic disrupting everyday life, there should be a discussion about how to address...
Healthcare has lagged behind other industries in moving to electronic formats for sensitive documents. This has been changing as organizations see opportunities...
Thermo Fisher Scientific sells the laboratory equipment that biopharmaceutical companies use in the research and development of new drugs. Its $20.9...
Merck is stopping development of two drugs as potential treatments for hospitalized Covid-19 patients, and one of those medicines will move...
By all accounts, Covid-19 has amplified the discussion around critical health disparities and inequities that have plagued the United States and its...
Relay Therapeutics has two cancer drugs in early clinical development and one more close behind—all of them discovered and developed with...
The Covid-19 pandemic served as a kick-starting catalyst for healthcare practices traditionally hesitant about adopting new technologies. From telehealth consultations to contactless...
Four biopharma startups are among the finalists in the INVEST Pitch Perfect contest, which is part of our annual INVEST conference April 19-23. This year, the...
During the Covid-19 pandemic, providers leaned heavily on travel nurses, as the demand for healthcare workers reached meteoric heights. But now a...
Serimmune, Inc., a leader in understanding the functional antibody repertoire’s role in human disease, announced this week that the company is enrolling...
Telemedicine and virtual care are no longer optional for healthcare practices. Covid-19 catapulted virtual care from an ancillary service to a staple...